CORRECTION article

Front. Immunol., 20 December 2022

Sec. Alloimmunity and Transplantation

Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1112027

Corrigendum: Mettl14-mediated m6A modification enhances the function of Foxp3+ regulatory T cells and promotes allograft acceptance

  • 1. Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

  • 2. Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China

  • 3. Institute of Neurology, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

In the published article, there was an error in Figure 4B as published. In the original publication of this article, the same GraphPad file was accidentally linked in Figures 4B, D, which is a mistake. The corrected Figure 4B and its caption appear below.

Figure 4

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

N6-methyladenosine, Mettl14, Treg function, transplantation, allograft acceptance

Citation

Liu Y, Yuan Y, Zhou Z, Cui Y, Teng Y, Huang H, Yuan H, Zhang Y, Yang L and Zhao G (2022) Corrigendum: Mettl14-mediated m6A modification enhances the function of Foxp3+ regulatory T cells and promotes allograft acceptance. Front. Immunol. 13:1112027. doi: 10.3389/fimmu.2022.1112027

Received

30 November 2022

Accepted

06 December 2022

Published

20 December 2022

Volume

13 - 2022

Edited and reviewed by

Sina NASERIAN, Hôpital Paul Brousse, France

Updates

Copyright

*Correspondence: Lu Yang, ; Gaoping Zhao,

This article was submitted to Alloimmunity and Transplantation, a section of the journal Frontiers in Immunology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics